Clinical Trials Sponsored by Ronald Weigel

Total 3107 results

Rigel Pharmaceuticals

Completed

Pilot Study of Fostamatinib Disodium/R935788 for the Treatment of Adult Refractory Immune Thrombocytopenic Purpura (ITP)

Purpura, Thrombocytopenic, Idiopathic

United States
Rigel Pharmaceuticals

Withdrawn

Open Label Study of Fostamatinib in the Treatment of IgA Nephropathy

IGA Nephropathy
Rigel Pharmaceuticals

Withdrawn

Efficacy and Safety Study of R935788 Tablets to Treat Systemic Lupus Erythematosus (SOLEIL)

Systemic Lupus Erythematosus
Rigel Pharmaceuticals

Completed

Treatment of Arthritis With Syk Kinase Inhibition (TASKI-1)

Rheumatoid Arthritis

United States, Mexico
Institute of Cancer Research, United Kingdom
Royal Marsden NHS Foundation Trust; Cancer Research UK; Ronald and Rita McAulay...

Active, not recruiting

The IMPACT Study - Identification of Men With a Genetic Predisposition to ProstAte Cancer

Prostate Cancer in BRCA1 and BRCA2 Carriers

United Kingdom
Rigel Pharmaceuticals

Completed

Open Label Study of R788 in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP)

Immune Thrombocytopenic Purpura

Spain, United States, Australia, Poland, United Kingdom, Canada, Czechia, Bulgaria, Romania, Austria, Denmark, Hungary, Italy, Netherlands, Norway
Rigel Pharmaceuticals

Completed

Double-Blind, Randomized, Placebo-Controlled, Multi-Center Phase 3 Study to Evaluate the Efficacy and Safety of Fostamatinib in COVID-19 Subjects

Pneumonia, Viral | Pneumonia | Covid19 | SARS (Severe Acute Respiratory Syndrome) | SARS-Associated Coronavirus as Cause of Disease Classified Elsewhere | SARS Pneumonia

United States, Argentina, Brazil, Mexico
Eiger BioPharmaceuticals

Completed

A Study to Evaluate Pegylated Interferon Lambda Monotherapy in Patients With Chronic Hepatitis Delta Virus Infection (LIMT)

Hepatitis D, Chronic

Israel, New Zealand, Pakistan
Rigel Pharmaceuticals

Completed

A Efficacy and Safety Study of Fostamatinib in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP) (FIT)

Immune Thrombocytopenic Purpura

Spain, Norway, Poland, Czechia, Germany, United States, Austria, Bulgaria, Romania
Rigel Pharmaceuticals

No longer available

Expanded Access of Fostamatinib in Patients With Persistent or Chronic Relapsing/Refractory ITP

Immune Thrombocytopenic Purpura
Rigel Dermatology

Completed

Topical Imiquimod Cream in Combination With Cryotherapy for the Treatment of Actinic Keratoses

Actinic Keratoses

United States
Rigel Pharmaceuticals

Completed

Efficacy and Safety Study of Fostamatinib Tablets to Treat B-cell Lymphoma

Lymphoma

United States
Rigel Pharmaceuticals

Completed

Efficacy and Safety Study of R935788 Tablets to Treat Rheumatoid Arthritis (Taski-2)

Rheumatoid Arthritis

United States, Mexico, Poland, Romania, Colombia, Bulgaria
Eiger BioPharmaceuticals

Terminated

Proof-of-concept Study Evaluating the Safety and Efficacy of EBP921 in Delta Hepatitis (HDV)

Hepatitis D

United States
Rigel Pharmaceuticals

Completed

7 Day Study of Mast Cell Inhibitor, R926112, in Patients With Symptomatic Seasonal Allergic Rhinitis

Rhinitis, Allergic, Seasonal
Rigel Pharmaceuticals

Terminated

Observational Study of Fostamatinib as Second Line Therapy in Adult Patients With Immune Thrombocytopenia (ITP) and Insufficient Response to a Prior Therapy

Immune Thrombocytopenia | ITP

United States
Eiger BioPharmaceuticals

Active, not recruiting

Phase 3 Study to Evaluate the Efficacy and Safety of Peginterferon Lambda for 48 Weeks in Patients With Chronic HDV (LIMT-2)

Hepatitis Delta Virus

United States, France, Belgium, Spain, Italy, Turkey, Bulgaria, Germany, Israel, Romania, Georgia, Moldova, Republic of
Eiger BioPharmaceuticals

Terminated

Open-Label Extension Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1) (LIBERTY2)

Pulmonary Arterial Hypertension

United States, Canada
Eiger BioPharmaceuticals

Completed

Safety and Tolerability Study of Clemizole Hydrochloride to Treat Hepatitis C in Subjects Who Are Treatment-Naive (CLEAN-1)

Hepatitis C
Eiger BioPharmaceuticals

Withdrawn

A Study of Lonafarnib With or Without Ritonavir in Patients With HDV (LOWR-5)

Chronic Delta Hepatitis
Rigel Pharmaceuticals

Completed

Safety and Efficacy Study of Fostamatinib to Treat Immunoglobin A (IgA) Nephropathy

IGA Nephropathy

United States, United Kingdom, Hong Kong, Taiwan, Austria, Germany
Rigel Pharmaceuticals

Completed

To Assess the Safety and Efficacy of R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca (DROPS)

Keratoconjunctivitis Sicca

United States
Rigel Pharmaceuticals

Completed

A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma (SITAR)

Asthma

United States, Canada
Rigel Pharmaceuticals

Completed

A Safety, Tolerability and Pharmacokinetics Study of R932348 Eye Drops in Patients With Dry Eye Disease

Keratoconjunctivitis Sicca

United States
Florian Beigel

Terminated

Colesevelam for the Treatment of Bile Acid Malabsorption in Patients With Crohn's Disease (COBAM)

Crohns Disease | Bile Acid Malabsorption

Germany
Ronald J. Rapoport, MD
Mallinckrodt

Unknown

Addition of H.P. Acthar Gel to Treatment Regimen of Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

United States
Donald Basel

Recruiting

Photodynamic Therapy for Benign Dermal Neurofibromas- Phase II

NEUROFIBROMATOSIS 1

United States
Ronald DeMatteo, M.D.

Recruiting

Infusion System for Hepatic Cancer

Intrahepatic Cholangiocarcinoma | Colorectal Cancer Metastatic to Liver

United States
Ronald Levy
National Institutes of Health (NIH)

Completed

Phase 1-2 of a CpG-Activated Whole Cell Vaccine Followed by Autologous Immunotransplant for MCL

Lymphoma, Mantle-Cell

United States
Donald T. Weed

Completed

Tadalafil in Treating Patients Undergoing Surgery for Cancer of the Oral Cavity or Oropharynx

Head and Neck Cancer

United States
True You Weight Loss

Active, not recruiting

ABLATE WEIGHT (Ablation Plus ESG for Weight Loss)

Obesity

United States
WeiWei Zhan

Recruiting

A Multicenter Trial of PLA vs. Surgery for Treating PTMC

Thyroid Cancer | Treatment Related Cancer

China, Italy
Renal Research Institute
Renal Solutions, Inc.

Terminated

Sorbent Treatment Prescriptions Pilot Study (Sorb2)

Renal Failure

United States
Renal Research Institute
Renal Solutions, Inc.

Unknown

Comparison of Conventional Dialysis and the Allient System

End Stage Renal Disease | Chronic Kidney Failure

United States
Duke University
Eigen

Recruiting

Trans-Rectal Ultrasound of the Female Pelvis for Real-Time MRI-US Fusion Based Needle Tracking ((TRUS))

Uterine Cancer

United States
Ronald Hoffman
Novartis

Unknown

LBH589 (Panobinostat) for the Treatment of Myelofibrosis

Primary Myelofibrosis | Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase | Post-Essential Thrombocythemia Related Myelofibrosis

United States
True You Weight Loss

Active, not recruiting

ABLATE WEIGHT 2 (Single-Stage Fundic Ablation Plus ESG for Weight Loss) (AW2)

Obesity

United States
Weight to Go Ltd

Unknown

Post-marketing Surveillance Study of A.M.I. Protector Adjustable Gastric Band

Obesity

United Kingdom
KK Women's and Children's Hospital
Ronald McDonald House Charities Singapore

Completed

Lifestyle Intervention of Obese Teenagers (LITE) Program

Adolescent Obesity | Lifestyle Intervention
Donald Mabbott

Recruiting

Effect of Metformin on Behaviour and the Brain in Children Treated for a Brain Tumour (Met Med Can)

Cognitive Impairment | Medulloblastoma, Childhood

Canada, Australia
Johns Hopkins University
Donald W. Reynolds Foundation

Recruiting

Imaging Techniques for Identifying Factors of Sudden Cardiac Death Risk

Sudden Cardiac Death

United States
Donald Trump, MD

Terminated

Oral Calcitriol With Ketoconazole in CRPC

Castration-resistant Prostate Cancer

United States
Donald Mathews
Masimo Corporation

Completed

Halo Index and Adaptive Alarm Thresholds During Routine PACU Inpatient Care: "Normal" vs. "Non-normal" Recovery (Halo)

Patients Recovering From Inpatient Surgery

United States
Roxall Medicina España S.A

Completed

Study to Evaluate the Efficacy and Safety of "Allergovac Poliplus" in Polysensitized Patients With Allergic Rhinitis/Rhinoconjunctivitis, With or Without Asthma (ARES)

Rhinitis, Allergic | Rhinoconjunctivitis

Spain
Roxall Medicina España S.A

Completed

Subcutaneous Immunotherapy in Patients Sensitized to Dermatophagoides Pteronyssinus (DPT)

Allergic Rhinoconjunctivitis

Spain
Roxall Medicina España S.A

Completed

Dose-response Study With Subcutaneous Immunotherapy of an Standardized Dermatophagoides Pteronyssinus (DPT) Extract

Allergic Rhinoconjunctivitis

Spain
Roxall Medicina España S.A

Completed

A Trial With Subcutaneous Immunotherapy (SCIT) in Patients With Rhinoconjunctivitis Sensitized to Olea Europaea and Phleum Pratense

Rhinoconjuntivitis

Spain
Roxall Medicina España S.A

Completed

Biological Standardization of D. Glomerata, L. Perenne, S. Cereale and O. Europaea Pollen Extracts

Sensitization to Allergens

Spain
Roxall Medicina España S.A

Completed

Determination of Biological Activity of Three Allergen Extracts

Hypersensitivity

Spain
Centro Universitario de Tonalá

Not yet recruiting

Effect of Folic Acid on the Presentation of Nuclear Abnormalities in People With a History Drug Abuse

Drug Abuse | Genotoxicity

Mexico

Clinical Trials Sponsored by Ronald Weigel

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cameroon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations